Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Mouse RARA (aa 444-462), Synthetic Peptide, Invitrogen™

Synthetic Peptide

Manufacturer:  Invitrogen PEP004

Catalog No. PEP004

This item has been discontinued by the manufacturer and is no longer available. Please call customer service for assistance: 1-800-766-7000.


Description

Description

Mouse Retinoic Acid (residues 444-462) Synthetic Peptide, PEP-004, from Invitrogen.

PEP-004 is a synthetic peptide whose sequence is from the C-terminal end of mouse retinoic acid receptor alpha (RAR alpha). The 19 amino acid sequence extends from amino acids 444 to 462 of RAR alpha. The sequence of PEP-004 is (amino to carboxy terminus): C-S-P-S-L-S-P-S-S-H-R-S-S-P-A-T-Q-S-PThis peptide may be used for neutralization and control experiments with the monoclonal and polyclonal antibodies that react with this product and human and mouse RAR*, catalog # MA1-810A and PA1-810A. Using a solution with equal weights per unit volume of peptide and corresponding antibody will yield a solution with a large molar excess of peptide that is able to competitively bind the antibody.Reconstitute with 0.1 ml of distilled water.
Specifications

Specifications

Synthetic Peptide
purified
50μg
Control
peptide with no preservative
C - S - P - S - L - S - P - S - S - H - R - S - S - P - A - T - Q - S - P
RUO
No preservative
Rara
Control
19401
Mouse
0.5 mg/mL
Lyophilized
Y
Mouse
-20° C, Avoid Freeze/Thaw Cycles
Mouse RARA (aa 444-462)
P11416
Peptide
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit